Primary |
Obesity |
37.5% |
Weight Control |
37.5% |
Palpitations |
12.5% |
Weight Increased |
12.5% |
|
Death |
18.2% |
Weight Increased |
18.2% |
Deep Vein Thrombosis |
9.1% |
Disorientation |
9.1% |
Menorrhagia |
9.1% |
Overdose |
9.1% |
Palpitations |
9.1% |
Pulmonary Hypertension |
9.1% |
Syncope |
9.1% |
|
Secondary |
Drug Use For Unknown Indication |
58.8% |
Product Used For Unknown Indication |
10.3% |
Weight Loss Diet |
4.4% |
Arthritis |
2.9% |
Fibromyalgia |
2.9% |
Obesity |
2.9% |
Pain |
2.9% |
Weight Decreased |
2.9% |
Blood Pressure |
1.5% |
Depression |
1.5% |
Diabetes Mellitus Non-insulin-dependent |
1.5% |
Hyperlipidaemia |
1.5% |
Hypertension |
1.5% |
Migraine |
1.5% |
Narcolepsy |
1.5% |
Sleep Disorder Therapy |
1.5% |
|
Drug Toxicity |
29.4% |
Unevaluable Event |
11.8% |
Fatigue |
5.9% |
Haemorrhage |
5.9% |
Malaise |
5.9% |
Memory Impairment |
5.9% |
Palpitations |
5.9% |
Pulmonary Embolism |
5.9% |
Pulmonary Oedema |
5.9% |
Thrombosis |
5.9% |
Urine Output Decreased |
5.9% |
Weight Decreased |
5.9% |
|
Concomitant |
Drug Use For Unknown Indication |
14.5% |
Product Used For Unknown Indication |
10.9% |
Contraception |
10.0% |
Pain |
8.8% |
Weight Decreased |
7.9% |
Depression |
7.4% |
Osteoporosis |
4.3% |
Premenstrual Syndrome |
4.2% |
Anxiety |
3.7% |
Acne |
3.5% |
Oral Contraception |
3.1% |
Smoking Cessation Therapy |
2.9% |
Bipolar Disorder |
2.7% |
Hypertension |
2.7% |
Bone Density Decreased |
2.6% |
Gastrooesophageal Reflux Disease |
2.4% |
Fibromyalgia |
2.3% |
Hormone Replacement Therapy |
2.1% |
Rheumatoid Arthritis |
2.1% |
Muscle Spasms |
1.9% |
|
Weight Increased |
11.5% |
Vomiting |
9.9% |
Pulmonary Embolism |
9.2% |
Weight Decreased |
9.2% |
Pain |
6.9% |
Cholecystitis Chronic |
6.1% |
Nausea |
5.3% |
Type 2 Diabetes Mellitus |
4.6% |
Injury |
3.8% |
Somnolence |
3.8% |
Abdominal Pain |
3.1% |
Abortion Spontaneous |
3.1% |
Arthralgia |
3.1% |
Cholelithiasis |
3.1% |
Diarrhoea |
3.1% |
Loss Of Consciousness |
3.1% |
Swollen Tongue |
3.1% |
Tardive Dyskinesia |
3.1% |
Thrombosis |
3.1% |
Abdominal Discomfort |
2.3% |
|
Interacting |
Decreased Appetite |
50.0% |
Smoking Cessation Therapy |
50.0% |
|
Drug Interaction |
66.7% |
Nausea |
33.3% |
|